Wang Samuel J, Fuller C David, Thomas Charles R
Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon 97239-3098, USA.
J Thorac Oncol. 2007 Mar;2(3):180-90. doi: 10.1097/JTO.0b013e318031cd4e.
Conditional survival (CS) is an accurate estimate of survival probability for patients who have already survived at least 1 year after diagnosis. The purpose of this study was to determine whether ethnicity plays a role in 5-year CS rates for patients with non-small cell lung cancer (NSCLC).
Using the Surveillance, Epidemiology, and End Results database, we analyzed 96,480 patients with NSCLC diagnosed between 1988 and 1995. Patients were divided into five ethnic groups: White (non-Hispanic), Hispanic, African American, Asian/Pacific Islander, and Native American/Alaskan. Using the life table method, we computed observed 5-year CS rates for patients who had already survived up to 5 years after diagnosis. Results were analyzed by stage, age, sex, and histology.
In general, 5-year CS rates increase for all ethnicities as time from diagnosis increases, but African Americans continued to have lower CS rates compared with other ethnic groups, even up to 5 years from diagnosis. When analyzed by stage, Hispanics with stage IV disease showed the greatest improvement in CS rate, increasing to 73% at 5 years from diagnosis. Among patients older than 70 years, African Americans had the lowest CS at 5 years--only 28%, compared with 40% to 47% for other groups. When analyzed by histology, Hispanics with large cell carcinoma had the worst CS rate (35% at 5 years).
For patients with NSCLC surviving a period of time after diagnosis, 5-year CS rates vary by ethnicity. CS can provide accurate prognostic information for patients with NSCLC who have already survived several years after diagnosis.
条件生存(CS)是对诊断后至少已存活1年的患者生存概率的准确估计。本研究的目的是确定种族是否在非小细胞肺癌(NSCLC)患者的5年条件生存率中起作用。
利用监测、流行病学和最终结果数据库,我们分析了1988年至1995年间诊断的96480例NSCLC患者。患者被分为五个种族组:白人(非西班牙裔)、西班牙裔、非裔美国人、亚裔/太平洋岛民和美洲原住民/阿拉斯加人。使用生命表法,我们计算了诊断后已存活长达5年的患者的观察到的5年条件生存率。结果按分期、年龄、性别和组织学进行分析。
总体而言,随着诊断时间的增加,所有种族的5年条件生存率均有所提高,但非裔美国人的条件生存率与其他种族相比仍然较低,甚至在诊断后长达5年时也是如此。按分期分析时,IV期疾病的西班牙裔患者的条件生存率改善最大,诊断后5年时增至73%。在70岁以上的患者中,非裔美国人5年时的条件生存率最低,仅为28%,而其他组为40%至47%。按组织学分析时,大细胞癌的西班牙裔患者的条件生存率最差(5年时为35%)。
对于诊断后存活一段时间的NSCLC患者,5年条件生存率因种族而异。条件生存可为诊断后已存活数年的NSCLC患者提供准确的预后信息。